¡¡¡¡12 Yannuzzi LA, Bardal AM, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124(4):450ª²460

¡¡¡¡13 Engelbrecht NE, Aaberg TM, Sung J, et al. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol 2002;120(3):320ª²324

¡¡¡¡14 Hee MR, Puliafito CA, Wong C, et al. Optical coherence tomography of macular holes. Ophthalmology 1995;102(5):748ª²756

¡¡¡¡15 Wilkins JR, Puliafito CA, Hee MR, et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology 1996;103(12):2142ª²2151

¡¡¡¡16 Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105(2):360ª²370

¡¡¡¡17 Hee MR, Puliafito CA, Wong C, et al. Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol 1995;120(1):65ª²74

¡¡¡¡18 Massin P, Allouch C, Haouchine B, et al. Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Ophthalmol 2000;130(6):732ª²739

¡¡¡¡19 Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahighª²resolution optical coherence tomography. Ophthalmology 2006;113(1):48ª²57

¡¡¡¡20 Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 2007;245(6):783ª²788

¡¡¡¡21 Lelia A, Tony H, Jay S, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahighª²resolution optical coherence tomography. Ophthalmology 2006;113(1):48ª²57

¡¡¡¡22 Drexler W, Morgner U, Ghanta RK, et al. Ultrahighª²resolution ophthalmic optical coherence tomography. Nat Med 2001;7(4):502ª²507

¡¡¡¡23 Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahighª²resolution optical coherence tomography. Arch Ophthalmol 2003;121(5):695ª²706

¡¡¡¡24 Gloesmann M, Hermann B, Schubert C, et al. Histologic correlation of pig retina radial stratification with ultrahighª²resolution optical coherence tomography. Invest Ophthalmol Vis Sci 2003;44(4):1696ª²1703

¡¡¡¡25 Barthelmes D, Gillies MC, Fleischhauer JC, et al. A case of idiopathic perifoveal telangiectasia preceded by features of cone dystrophy. Eye 2007;21(12):1542ª²1543

¡¡¡¡26 Maberley DA, Yannuzzi LA, Gitter K, et al. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. Ophthalmology 1999;106(12):2248ª²2252

¡¡¡¡27 Park DW, Schatz H, McDonald HR, et al. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 1997;104(11):1838ª²1846

¡¡¡¡28 Potter MJ, Szabo SM, Chan EY, et al. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002;133(1):149ª²151

¡¡¡¡29 Berger AS, McCuen BW 2nd, Brown GC, et al. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 1997;17(2):94ª²98

¡¡¡¡30 Spaide RF. Rationale for combination therapies for choroidal neovascularization. Ophthalmol 2006;141(1):149ª²156

¡¡¡¡31 Rishi P, Shroff D, Rishi E. Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol 2008;246(4):619ª²621

¡¡¡¡32 Penn JS, Rajaratnam VS, Collier RJ, et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42(1):283ª²290

¡¡¡¡33 Eandi CM, Ober MD, Freund KB, et al. Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study. Retina 2006;26(7):780ª²785

¡¡¡¡34 Park D, Schatz H, McDonald HR, et al. Fibrovascular tissue in bilateral juxtafoveal telangiectasis. Arch Ophthalmol 1996;114(9):1092ª²1096

¡¡¡¡35 McNatt LG, Weimer L, Yanni J, et al. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. J Ocul Pharm Ther 1999;15(5):413ª²423

¡¡¡¡36 Ayyala RS, Cruz DA, Margo CE, et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Opthalmol 1998;126(4):602ª²604

¡¡¡¡37 Moroi SE, Gottfredsdottir MS, Schteingart MT, et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999;106(5):1024ª²1029

¡¡¡¡38 Lynch SS, Cheng CM. Bevacizumab for neovascular ocular diseases. Ann Pharmacother 2007;41(4):614ª²625

¡¡¡¡39 Moon SJ, Berger AS, Tolentino MJ, et al. Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surg Lasers Imaging 2007;38(2):164ª²166

¡¡¡¡40 Schulze S, Mennel S. Treatment of idiopathic juxtaforeolar retinal telangiectasis with bevacizumab(avastin). Klin Monatsbl Augenheilkd 2007;224(10):787ª²790

¡¡¡¡41 Charbel Issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007;114(9):1736ª²1742

¡¡¡¡42 Gamulescu MA, Walter A, Sachs H, et al. Bevacizumab in the treatment of idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol 2008;246(8):1189ª²1193

¡¡¡¡43 Robert C, Michael L, James C, et al. Longª²team juxtafoveal retinal telangiectasia. Retina 2005;25:727ª²735

ÉÏÒ»Ò³  [1] [2] [3]